Atripla and Liver Disorder

This page shows results related to Atripla and Liver Disorder from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Atripla and Liver Disorder

Age

40-49 Years	13
30-39 Years	7
50-59 Years	7
20-29 Years	2
>60 Years	1

Gender

Male: 83%
Female: 18%

Outcome

What were the most common outcomes of those reporting Liver Disorder?

Hospitalization	27
Other	13
Death	6
Life Threatening	5
Disability	3

Reporter

Who most commonly reported Liver Disorder?

Physician	22
Other	5
Consumer	2

Therapy

Of those reporting Liver Disorder, why were they taking Atripla?

Hiv Infection	34
Antiviral Treatment	1

Other Medications

Which medications reported to the FDA are most commonly associated with Liver Disorder?

Remicade	684
Vioxx	593
Lipitor	587
Nexavar	443
Exjade	335
	Show More
Fosamax	327
Humira	315
Seroquel	308
Infliximab	302
Avonex	261
Crestor	257
Tegretol	250
Enbrel	237
Cymbalta	235
Aspirin	218
Iressa	214
Gleevec	202
Accutane	198
Methotrexate	192
Lamisil	188
Prednisolone	180
Diovan	171
Kaletra	166
Voltaren	160
Zyprexa	158
Cyclophosphamide	153
Arava	151
Lamictal	150
Promacta	148
Lyrica	145
Tracleer	145
Rebif	144
Neoral	143
Ketek	140
Pepcid Rpd	139
Acetaminophen	135
Avandia	128
Thymoglobulin	127
Paxil	123
Zometa	123
Cyclosporine	118
Clarithromycin	118
Panaldine	117
Revlimid	117
Tysabri	114
Plavix	114
Prograf	111
Micardis	110
Januvia	105
Pepcid	105
Risperdal	105

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Atripla, view the complete Atripla adverse event report.

Scientific Publications on Liver Disorder

Comments

Share your experience with Atripla and Liver Disorder.